alt Hacker NewsTo be clear, I don't think GLP1 agonists are "negative." I think the blend of environmental, food supply, and other factors that led many adults, in the US and elsewhere, to need obesity intervention is the negative. GLP1 agonists are an inherent crutch.
Much like if we geoengineered cloud seeding or similar light blocking and fail to reduce CO2, the treatment masks the cause and can lead to worse outcomes globally (even if some folks are better off - and I hope they are!).
I don’t agree they are a crutch.
However, if they are, then modern life is a sledge hammer that’s constantly breaking your legs.
Our (US, UK, Australia and so on) life styles and food chain have created this obesity problem.
We are now a sedentary population, and low-nutrient high-calorie food is being made readily available to stressed, tired, overworked, and economically challenged people. When you are stressed and tired, you don’t make the best choices!
These drugs are not so much a crutch as they are a rescue helicopter!
We still need education though.
These drugs might reduce hunger, but they won’t stop you from consuming junk-food. People are used to overeating, and a feeling full isn’t always what’s stopping them from eating!
So we do absolutely need to address the root of problem….